The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
- Valuing and accessing medicines
- RESEARCH, DEVELOPMENT AND MANUFACTURING
- WORKING IN PARTNERSHIP
- Industry Reputation
- International Policy, Trade & IP
- Health Data
Valuing and accessing medicines
Ensuring value, access and uptake of innovative medicines and vaccines, now and in the future
Medicines bring huge value to NHS patients. The development of new medicines is uncertain, costly, and involves significant rates of failure. The pharmaceutical industry spends $160 billion per year on research and development.The private sector produces nearly all the medicines and vaccines available to us. Companies need to make a profit – and a return – on global investment in order to maintain investment in the next generation of medicines.
RESEARCH, DEVELOPMENT AND MANUFACTURING
Improving the UK's attractiveness for industry, research, development and manufacturing
We're helping to build a thriving environment for medicine discovery so the UK can be the best place in the world to research and develop new medicines and vaccines.
WORKING IN PARTNERSHIP
Building better partnerships between industry and NHS and across the Life Sciences sector
We have a long-standing positive relationship with the NHS, and a record of facilitate the same across various parties across the Life Sciences sector. We believe in focusing collaboration on where it can add the most value in making innovation as widely available to patients as possible.
Industry Reputation
Building a stronger industry reputation in the UK
Everywhere, every day someone relies on the results of our work to ensure their health and wellbeing. We are proud of this and are committed to working with a wide range of people - patients, doctors, nurses, regulators and governments - in order to deliver medicines in an ethically responsible way. Patients are at the heart of everything that we do.
International Policy, Trade & IP
Providing international leadership and driving global policy
The ABPI is working to ensure that the UK has the best relationship with our international partners for patients, public health and the life sciences sector.
Health Data
Improving the UK's health data capability and industry's access to data
We aim to harness the UK’s health data to support the efficient design, feasibility, recruitment and conduct of the full range of clinical trials. We are helping the UK make the most of health-related data for future research and development into new medicines.
Latest news
ABPI response to the mini-Budget
The Chancellor has set out the Government's plan for growth, aimed at releasing the huge potential in the British economy.
ABPI response to the Government's Plan for Patients
The Government has today published its Plan for Patients, so that patients receive easier access to NHS and social care this winter and next.
ABPI statement on the death of Aisling Burnand
The former CEO of the Association of Medical Research Charities, Aisling Burnand, has died from bowel cancer.
Susan Rienow of Pfizer named Vice-President of the ABPI
The ABPI Board has confirmed that Susan Rienow, Country President of Pfizer, has been elected as Vice President.
Latest blogs and events
The Innovative Medicines Fund - Good news for patients but has an opportunity been missed to be more ambitious?
NHS England and Improvement (NHSE/I) has announced the launch of the Innovative Medicines Fund. The ABPI’s Director of Value and Access Policy, Paul Catchpole, provides further commentary on the announcement.
Working together, we are all determined to create more medicines for pregnant women
Steve Hoare, the ABPI's Head of Safety and Quality, talks about how industry is trying to address the lack of medicines approved for pregnant women.
Worth the wait – The Goldacre review
Our thoughts on Professor Ben Goldacre’s “Better, broader, safer” report into health data.
Innovative medicines can bring hope to people with rare diseases – let’s get them to patients
England’s Action Plan for Rare Diseases contains important commitments to ensure that people with rare diseases get faster diagnosis, better care and timelier access to the treatments they desperately need.
Key content hubs
This covers the latest research from the ABPI-Ipsos attitudes towards pharmaceutical companies in the UK study.
We stand in solidarity with the people of Ukraine and condemn the invasion of their country. As an industry dedicated to saving lives, we stand for peace.
As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to COVID-19.
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
Better access to new medicines would help to reduce heath inequalities, tackle the backlog, and generate investment in UK life sciences.
— ABPI (@ABPI_UK) September 26, 2022
Read our report to find out more @thefabians #Lab22 https://t.co/ADIMWdhbDh
.@torbettr said 3 things can help tackle pressures on the NHS & improve health inequalities:
— ABPI (@ABPI_UK) September 26, 2022
1⃣Improving access to the right medicines for patients
2⃣Improving access to clinical research opportunities 3⃣Harnessing data to drive improved outcomes #Lab22 @thefabians https://t.co/FlaMClIDoH
Our Chief Executive @torbettr is at #Lab22 discussing tackling health inequalities this evening.
— ABPI (@ABPI_UK) September 26, 2022
The debate promises to be fascinating - now underway with @AnitaCTHF, @DrAnnaDixon @PauletteHamilto @LizTwistMP and @CllrSalmaArif @thefabians https://t.co/IHVHThVPxP
Looking forward to a fascinating debate. @thefabians https://t.co/RY5EEwM2Y1
— ABPI (@ABPI_UK) September 26, 2022
The Pharmaceutical Industry in the UK
![R and D Investment [3]](/media/ouqnhlry/figures-r-d-investment-5-0bn.jpg)
Members
Online members portal (ABPI Meetings via Adam.ai)
ABPI members can log in for bespoke content and services.